Publications
5530 Results
- Journal / Conference
- ASCO 8:130(504)
- Year
- 1989
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8216/38
BCG versus adriamycin intravesical therapy for in situ and papillary transitional cell carcinoma of the urinary bladder: A Southwest Oncology Group study
- Journal / Conference
- ASCO 8:250(#975)
- Year
- 1989
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8229/30
Combination chemotherapy is superior to hemibody irradiation(HXRT) for remission consolidation in multiple myeloma (MM): A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- ASCO 8:158(#616)
- Year
- 1989
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8321
Phase II trial of cisplatin (CP) and 5-fluorouracil (5FU) with or without allopurinol (ALL) for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 8:269(#1050)
- Year
- 1989
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8323
Evaluation of fludarabine phosphate (FLAMP) in patients with advanced mycosis fungoides (MF). A Southwest Oncology Group study.
- Journal / Conference
- ASCO 8:201(#783)
- Year
- 1989
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8326/27
Increased risk of early death (ED) with high dose ara-C (HDAC)and m-AMSA compared to HDAC alone or HDAC and mitoxantrone (MITOX) inhigh risk nonlymphocytic leukemia (ANL)
- Journal / Conference
- ASCO 8:101(#392)
- Year
- 1989
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8390
5-fluorouracil (5FU) and folinic acid (FA): for the treatment ofmetastatic gastric cancer.
- Journal / Conference
- ASCO 8:155(#605)
- Year
- 1989
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8407
Carboplatin therapy in advanced endometrial cancer: A SouthwestOncology Group study.
- Journal / Conference
- ASCO 8:151(#588)
- Year
- 1989
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved efficacy of carboplatin (CarboP)/cyclophosphamide (CPA)vs cisplatin (CisP)/CPA: Preliminary report of a phase III, randomizedtrial in stages III-IV, suboptimal ovarian cancer (OVCA).
- Journal / Conference
- ASCO 8:128(#498)
- Year
- 1989
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8424